ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer.

Chengfei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.